Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""adenocarcinoma"" wg kryterium: Temat


Tytuł :
Primary enteric adenocarcinoma: A case report and literature review.
Autorzy :
Long Y; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Changsha 410011. .
Liu X; Department of Critical Care Medicine, Hunan Want Want Hospital, Changsha 410016.
DU H; Department of Geratology, Ninth Hospital of Changsha, Changsha 410001.
Zhang K; Department of Pathology, Second Xiangya Hospital, Changsha 410011, China.
Peng H; Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Changsha 410011. .
Pokaż więcej
Transliterated Title :
原发性肺肠型腺癌1例并文献复习.
Źródło :
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences [Zhong Nan Da Xue Xue Bao Yi Xue Ban] 2020 Dec 28; Vol. 45 (12), pp. 1504-1508.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Adenocarcinoma*/surgery
Lung Neoplasms*
Adenocarcinoma of Lung ; Humans ; Lung ; Male
Czasopismo naukowe
Tytuł :
Clinical Value of F-FDG PET/CT in Prediction of Visceral Pleural Invasion of Subsolid Nodule Stage I Lung Adenocarcinoma.
Autorzy :
Chen Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, 58#, Zhongshan 2 Road, Guangzhou 510080, China.
Jiang S; Department of Radiology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, China.
Li Z; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, 58#, Zhongshan 2 Road, Guangzhou 510080, China.
Rao L; Department of Radiology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
Zhang X; Department of Nuclear Medicine, The First Affiliated Hospital of Sun Yat-Sen University, 58#, Zhongshan 2 Road, Guangzhou 510080, China. Electronic address: .
Pokaż więcej
Źródło :
Academic radiology [Acad Radiol] 2020 Dec; Vol. 27 (12), pp. 1691-1699. Date of Electronic Publication: 2020 Feb 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Adenocarcinoma of Lung/diagnostic imaging ; Fluorodeoxyglucose F18 ; Humans ; Pleura/diagnostic imaging ; Positron Emission Tomography Computed Tomography ; Radiopharmaceuticals ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Therapeutic Interception of Early Lung Adenocarcinoma Progression: Not Just How, but When?
Autorzy :
Borczuk AC; Pathology and Laboratory Medicine Weill Cornell Medicine New York, New York.
Pokaż więcej
Źródło :
American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2021 Jan 01; Vol. 203 (1), pp. 8-9.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Adenocarcinoma*
Lung Neoplasms*
Pulmonary Disease, Chronic Obstructive*
Adenocarcinoma of Lung ; Disease Progression ; Humans ; Lipocalin-2
Opinia redakcyjna
Tytuł :
Radiomics to Predict Invasiveness of Part-Solid Adenocarcinoma of the Lung.
Autorzy :
Nishino M; From the Department of Imaging, Dana-Farber Cancer Institute, Boston, Mass; and Department of Radiology, Brigham and Women's Hospital, 450 Brookline Ave, Boston, MA 02215.
Pokaż więcej
Źródło :
Radiology [Radiology] 2020 Nov; Vol. 297 (2), pp. 459-461. Date of Electronic Publication: 2020 Aug 25.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Adenocarcinoma of Lung/diagnostic imaging ; Humans ; Lung/diagnostic imaging ; Thorax ; Tomography, X-Ray Computed
Opinia redakcyjna
Tytuł :
Growth Assessment of Pulmonary Adenocarcinomas Manifesting as Subsolid Nodules on CT: Comparison of Diameter-Based and Volume Measurements.
Autorzy :
de Margerie-Mellon C; Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA. Electronic address: .
Gill RR; Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Monteiro Filho AC; Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Heidinger BH; Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA; Department of Biomedical Imaging and Image-guided therapy, Medical University of Vienna, Vienna, Austria.
Onken A; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
VanderLaan PA; Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.
Bankier AA; Department of Radiology, Beth Israel Deaconess Medical Center and Harvard Medical School, 330 Brookline Avenue, Boston, MA 02215, USA.
Pokaż więcej
Źródło :
Academic radiology [Acad Radiol] 2020 Oct; Vol. 27 (10), pp. 1385-1393. Date of Electronic Publication: 2019 Nov 13.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Solitary Pulmonary Nodule*/diagnostic imaging
Adenocarcinoma of Lung/diagnostic imaging ; Aged ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
How to treat early-stage lung adenocarcinoma based on the size of the clinical solid component?
Autorzy :
Ma H; Department of Respiratory Disease, People's Hospital of Zhengzhou, Zhengzhou, Henan Province, China.
Zhang G; Department of Thoracic Surgery, First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
Pokaż więcej
Źródło :
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2020 Sep 01; Vol. 58 (3), pp. 662.
Typ publikacji :
Letter; Comment
MeSH Terms :
Adenocarcinoma*/surgery
Lung Neoplasms*
Adenocarcinoma of Lung/diagnostic imaging ; Humans ; Prognosis
Opinia redakcyjna
Tytuł :
Reply to Ma and Zhang.
Autorzy :
Han SJ; Department of Thoracic and Cardiovascular Surgery, Chungnam National University Hospital, Daejeon, Korea.
Jeon JH; Department of Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery [Eur J Cardiothorac Surg] 2020 Sep 01; Vol. 58 (3), pp. 662-663.
Typ publikacji :
Letter; Comment
MeSH Terms :
Adenocarcinoma*
Lung Neoplasms*
Adenocarcinoma of Lung ; Humans ; Prognosis
Opinia redakcyjna
Tytuł :
CT Diagnosis of Lung Adenocarcinoma: Radiologic-Pathologic Correlation and Growth Rate.
Autorzy :
Kuriyama K; From the Department of Radiology, National Hospital Organization/Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan (K.K.); and Department of Radiology, Graduate School of Medicine/Faculty of Medicine, Osaka University, Osaka, Japan (M.Y.).
Yanagawa M; From the Department of Radiology, National Hospital Organization/Osaka National Hospital, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan (K.K.); and Department of Radiology, Graduate School of Medicine/Faculty of Medicine, Osaka University, Osaka, Japan (M.Y.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2020 Oct; Vol. 297 (1), pp. 199-200. Date of Electronic Publication: 2020 Aug 04.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Adenocarcinoma*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Adenocarcinoma of Lung/diagnostic imaging ; Humans ; Thorax ; Tomography, X-Ray Computed
Opinia redakcyjna
Tytuł :
The Newly Described Filigree Pattern Is an Expansion of the Micropapillary Adenocarcinoma Concept Rather Than a Proposed New Subtype.
Autorzy :
Emoto K; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
Tan KS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.
Rekhtman N; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
Adusumilli PS; Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York; Solid Tumors Cell Therapy, Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, New York.
Travis WD; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: .
Pokaż więcej
Źródło :
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Jul; Vol. 15 (7), pp. e121-e124.
Typ publikacji :
Letter; Comment
MeSH Terms :
Adenocarcinoma*
Lung Neoplasms*
Adenocarcinoma of Lung ; Humans
Opinia redakcyjna
Tytuł :
Hepatoid adenocarcinoma of the lung and the review of the literature.
Autorzy :
Tonyali O; Department of Medical Oncology, Istanbul Oncology Hospital, Istanbul, Turkey.
Gonullu O; Department of Pathology, Agri State Hospital, Agri, Turkey.
Ozturk MA; Department of Medical Oncology, VM Medical Park Pendik, Istanbul, Turkey.
Kosif A; Department of Thoracic Surgery, Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul, Turkey.
Civi OG; Department of Nuclear Medicine, Istanbul Oncology Hospital, Istanbul, Turkey.
Pokaż więcej
Źródło :
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2020 Sep; Vol. 26 (6), pp. 1505-1510. Date of Electronic Publication: 2020 Feb 10.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Adenocarcinoma/*therapy
Carcinoma, Non-Small-Cell Lung/*therapy
Lung Neoplasms/*therapy
Adenocarcinoma/pathology ; Adenocarcinoma of Lung/pathology ; Adenocarcinoma of Lung/therapy ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Middle Aged ; Prognosis ; alpha-Fetoproteins/metabolism
Czasopismo naukowe
Tytuł :
Rare Histological Variants of Prostate Adenocarcinoma: A National Cancer Database Analysis.
Autorzy :
Bronkema C; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.; Wayne State University School of Medicine, Detroit, Michigan.
Arora S; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Sood A; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Dalela D; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Keeley J; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Borchert A; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Baumgarten L; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Rogers CG; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Peabody JO; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Menon M; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Abdollah F; Vattikuti Urology Institute, Henry Ford Hospital, Detroit, Michigan.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2020 Aug; Vol. 204 (2), pp. 260-266. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Prostatic Neoplasms/*pathology
Adenocarcinoma/mortality ; Adenocarcinoma, Mucinous/mortality ; Adenocarcinoma, Mucinous/pathology ; Carcinoma, Adenosquamous/mortality ; Carcinoma, Adenosquamous/pathology ; Carcinoma, Ductal/mortality ; Carcinoma, Ductal/pathology ; Carcinoma, Signet Ring Cell/mortality ; Carcinoma, Signet Ring Cell/pathology ; Carcinosarcoma/mortality ; Carcinosarcoma/pathology ; Databases, Factual ; Humans ; Male ; Neoplasm Staging ; Prostatic Neoplasms/mortality ; Survival Rate ; United States
Czasopismo naukowe
Tytuł :
A Novel Intergenic LSM14A-RET Fusion Variant in a Patient With Lung Adenocarcinoma.
Autorzy :
Lv Y; Department of Medical Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, P.R. China.
Ling F; Department of Medical Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, P.R. China.
Zhang J; Medical Department, 3D Medicines Inc., Shanghai, P.R. China.
Xiao M; Medical Department, 3D Medicines Inc., Shanghai, P.R. China.
Mao W; Department of Medical Oncology, The Jiangyin Clinical College of Xuzhou Medical University, Jiangyin, P.R. China. Electronic address: .
Pokaż więcej
Źródło :
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2020 Apr; Vol. 15 (4), pp. e52-e53.
Typ publikacji :
Case Reports; Letter
MeSH Terms :
Adenocarcinoma*/genetics
Lung Neoplasms*/genetics
Adenocarcinoma of Lung/genetics ; Humans ; Oncogene Proteins, Fusion/genetics ; Proto-Oncogene Proteins c-ret
Raport
Tytuł :
TENET 2.0: Identification of key transcriptional regulators and enhancers in lung adenocarcinoma.
Autorzy :
Mullen DJ; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Department of Surgery, Keck School of Medicine, University of Southern California, CA, United States of America.
Yan C; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Department of Surgery, Keck School of Medicine, University of Southern California, CA, United States of America.
Kang DS; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Department of Surgery, Keck School of Medicine, University of Southern California, CA, United States of America.
Zhou B; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, CA, United States of America.
Borok Z; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Hastings Center for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Keck School of Medicine, University of Southern California, CA, United States of America.
Marconett CN; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Department of Surgery, Keck School of Medicine, University of Southern California, CA, United States of America.
Farnham PJ; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.
Offringa IA; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.; Department of Surgery, Keck School of Medicine, University of Southern California, CA, United States of America.
Rhie SK; Department of Biochemistry and Molecular Medicine and the Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, CA, United States of America.
Pokaż więcej
Źródło :
PLoS genetics [PLoS Genet] 2020 Sep 14; Vol. 16 (9), pp. e1009023. Date of Electronic Publication: 2020 Sep 14 (Print Publication: 2020).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung/*genetics
Epigenesis, Genetic/*genetics
Regulatory Elements, Transcriptional/*genetics
Adenocarcinoma/genetics ; Adult ; Aged ; Cell Cycle Proteins/genetics ; Epigenomics ; Forkhead Box Protein M1/genetics ; Gene Expression Regulation, Neoplastic/genetics ; Genes, Homeobox ; Humans ; Lung/metabolism ; Lung Neoplasms/genetics ; Male ; Middle Aged ; Regulatory Sequences, Nucleic Acid/genetics
Czasopismo naukowe
Tytuł :
Testing for ROS1, ALK, MET, and HER2 rearrangements and amplifications in a large series of biliary tract adenocarcinomas.
Autorzy :
Augustin J; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.
Gabignon C; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.
Scriva A; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.
Menu L; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.
Calmel C; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.
Scatton O; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.; Service de Chirurgie Hépato-Biliaire et Transplantation Hépatique, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.
Paye F; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.; Service de Chirurgie Digestive, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.
Fléjou JF; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.
Praz F; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.; Centre National de la Recherche Scientifique (CNRS), Paris, France.
Cervera P; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France. .; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France. .
Wendum D; Service d'Anatomie et Cytologie Pathologiques, AP-HP, Hôpital Saint Antoine, 75012, Paris, France.; INSERM UMR_S 938, Centre de Recherche Saint-Antoine (CRSA), Faculté de Médecine Sorbonne Université, 75012, Paris, France.
Pokaż więcej
Źródło :
Virchows Archiv : an international journal of pathology [Virchows Arch] 2020 Jul; Vol. 477 (1), pp. 33-45. Date of Electronic Publication: 2020 May 24.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*genetics
Gene Rearrangement/*genetics
Protein-Tyrosine Kinases/*genetics
Proto-Oncogene Proteins/*genetics
Receptor, ErbB-2/*genetics
Adenocarcinoma/pathology ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Anaplastic Lymphoma Kinase/genetics ; Biliary Tract/pathology ; Humans ; In Situ Hybridization, Fluorescence/methods ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Proto-Oncogene Proteins c-met/genetics
Czasopismo naukowe
Tytuł :
MUC5AC enhances tumor heterogeneity in lung adenocarcinoma with mucin production and is associated with poor prognosis.
Autorzy :
Dong Y; Department of Pathology, Key Laboratory of Head and Neck Molecular Diagnosis Pathology, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China, and.; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Zhou L; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Zhao D; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Li K; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Liu Z; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Che N; Department of Pathology, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
Liu H; Department of Pathology, Key Laboratory of Head and Neck Molecular Diagnosis Pathology, Beijing TongRen Hospital, Capital Medical University, Beijing 100730, China, and.
Pokaż więcej
Źródło :
Japanese journal of clinical oncology [Jpn J Clin Oncol] 2020 Jun 10; Vol. 50 (6), pp. 701-711.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Adenocarcinoma of Lung/*genetics
Lung Neoplasms/*genetics
Mucin 5AC/*genetics
Thyroid Nuclear Factor 1/*genetics
Adenocarcinoma of Lung/metabolism ; Adenocarcinoma of Lung/surgery ; Adenocarcinoma, Mucinous/genetics ; Adenocarcinoma, Mucinous/metabolism ; Adenocarcinoma, Mucinous/surgery ; Adult ; Aged ; Aged, 80 and over ; ErbB Receptors/genetics ; Female ; Humans ; Immunohistochemistry ; Lung Neoplasms/metabolism ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Mucin 5AC/analysis ; Mutation ; Prognosis ; Proto-Oncogene Proteins p21(ras)/genetics ; Thyroid Nuclear Factor 1/analysis
Czasopismo naukowe
Tytuł :
Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival.
Autorzy :
Runkel M; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany. .
Verst R; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.
Spiegelberg J; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.
Fichtner-Feigl S; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.
Hoeppner J; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.; Department of Surgery, University Medical Center Schleswig-Holstein, Campus Luebeck, Luebeck, Germany.
Glatz T; Department of General - and Visceral Surgery, Medical Center, University of Freiburg, Hugstetterstrasse 55, 79106, Freiburg, Germany.; Department of Surgery, Marien Hospital Herne, Ruhr-University Bochum, 44625, Herne, Germany.
Pokaż więcej
Źródło :
BMC surgery [BMC Surg] 2021 Jan 13; Vol. 21 (1), pp. 35. Date of Electronic Publication: 2021 Jan 13.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*drug therapy
Adenocarcinoma/*surgery
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Esophageal Neoplasms/*drug therapy
Esophageal Neoplasms/*surgery
Neoadjuvant Therapy/*methods
Stomach Neoplasms/*drug therapy
Stomach Neoplasms/*surgery
Adenocarcinoma/mortality ; Adenocarcinoma/pathology ; Esophageal Neoplasms/mortality ; Esophageal Neoplasms/pathology ; Esophagogastric Junction ; Female ; Fluorouracil/administration & dosage ; Humans ; Leucovorin/administration & dosage ; Male ; Organoplatinum Compounds/administration & dosage ; Oxaliplatin ; Retrospective Studies ; Stomach Neoplasms/mortality ; Stomach Neoplasms/pathology ; Survival Rate ; Taxoids/administration & dosage ; Treatment Outcome
Czasopismo naukowe
Tytuł :
CYLD expression in dendritic cells involved in the immunoregulation of pulmonary adenocarcinoma via NF-κB pathway.
Autorzy :
Yu Q; Department of Radiology, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Lei Y; Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Huang Y; Department of Thoracic Surgery, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhang J; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Chen Y; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Chen K; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Lin J; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Sun S; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Lin X; Department of Thoracic Surgery, Fujian Provincial Hospital, Provincial Clinical College of Fujian Medical University, Fuzhou, China.
Pokaż więcej
Źródło :
Artificial cells, nanomedicine, and biotechnology [Artif Cells Nanomed Biotechnol] 2020 Dec; Vol. 48 (1), pp. 137-142.
Typ publikacji :
Journal Article
MeSH Terms :
Immunomodulation*
Adenocarcinoma of Lung/*immunology
Adenocarcinoma of Lung/*pathology
Dendritic Cells/*metabolism
Deubiquitinating Enzyme CYLD/*metabolism
NF-kappa B/*metabolism
Signal Transduction/*immunology
Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/metabolism ; Animals ; CD4-Positive T-Lymphocytes/cytology ; Cell Proliferation ; Dendritic Cells/immunology ; Deubiquitinating Enzyme CYLD/deficiency ; Deubiquitinating Enzyme CYLD/genetics ; Disease Progression ; Gene Knockout Techniques ; Mice
Czasopismo naukowe
Tytuł :
Lung cancer pathogenesis and poor response to therapy were dependent on driver oncogenic mutations.
Autorzy :
Sun X; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China. Electronic address: .
Li K; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Zhao R; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Sun Y; Department of Anesthesiology and Operation, Operating Centre, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Xu J; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China; Department of General Surgery, the People's Hospital of Shanyang County, Luonan City, Shaanxi Province 726411, China.
Peng ZY; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Song RD; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Ren H; Department of Thoracic Surgery, the Second Department of Thoracic Surgery, Department of Thoracic Surgery and Oncology, Cancer Center, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an City, Shaanxi Province 710061, China.
Tang SC; University of Mississippi Medical Center, Cancer Center and Research Institute, 2500 North State Street, Jackson, MS 39216, USA. Electronic address: .
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 Jan 15; Vol. 265, pp. 118797. Date of Electronic Publication: 2020 Dec 04.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung/*genetics
Carcinogenesis/*genetics
Lung Neoplasms/*genetics
Mutation/*genetics
Oncogenes/*genetics
Smoking/*genetics
Adenocarcinoma of Lung/pathology ; Adenocarcinoma of Lung/therapy ; Aged ; Biomarkers, Tumor/genetics ; Carcinogenesis/drug effects ; Carcinogenesis/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Lung Neoplasms/therapy ; Male ; Middle Aged ; Mutation/drug effects ; Oncogenes/drug effects ; Smoking/pathology ; Smoking/therapy ; Survival Rate/trends ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Primary Tumor Resection Is Associated with a Better Outcome among Advanced EGFR-Mutant Lung Adenocarcinoma Patients Receiving EGFR-TKI Treatment.
Autorzy :
Tseng JS; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Hsu KH; Division of Critical Care and Respiratory Therapy, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Zheng ZR; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.
Yang TY; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
Chen KC; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.; Department of Applied Chemistry, National Chi Nan University, Nantou, Taiwan.
Huang YH; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Su KY; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.
Yu SL; Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan.; Center of Genomic Medicine, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Pathology and Graduate Institute of Pathology, College of Medicine, National Taiwan University, Taipei, Taiwan.; Center for Optoelectronic Biomedicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Chang GC; Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, .; Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, .; Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan, .; Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan, .; School of Medicine, Chung Shan Medical University, Taichung, Taiwan, .; Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, .
Pokaż więcej
Źródło :
Oncology [Oncology] 2021; Vol. 99 (1), pp. 32-40. Date of Electronic Publication: 2020 Sep 07.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung/*surgery
Neoplasm Recurrence, Local/*surgery
Protein Kinase Inhibitors/*administration & dosage
Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/pathology ; Aged ; Aged, 80 and over ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/genetics ; Female ; Humans ; Male ; Middle Aged ; Mutation/genetics ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/genetics ; Progression-Free Survival ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Ten-year survival after pathologic complete response in rectal adenocarcinoma.
Autorzy :
Sell NM; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Qwaider YZ; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Goldstone RN; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Cauley CE; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Cusack JC; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Ricciardi R; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Bordeianou LG; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Berger DL; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Kunitake H; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
Pokaż więcej
Źródło :
Journal of surgical oncology [J Surg Oncol] 2021 Jan; Vol. 123 (1), pp. 293-298. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma/*mortality
Chemoradiotherapy, Adjuvant/*mortality
Digestive System Surgical Procedures/*mortality
Neoadjuvant Therapy/*mortality
Neoplasm Recurrence, Local/*mortality
Rectal Neoplasms/*mortality
Adenocarcinoma/secondary ; Adenocarcinoma/therapy ; Adult ; Aged ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Neoplasm Recurrence, Local/therapy ; Prognosis ; Rectal Neoplasms/pathology ; Rectal Neoplasms/therapy ; Retrospective Studies ; Survival Rate
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies